Skip to content

An online self-management intervention for patients with hand osteoarthritis - a randomised controlled trial

An online self-management intervention for patients with hand osteoarthritis - a randomised controlled trial - Online self-management in hand OA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50628
Enrollment
70
Registered
2016-04-20
Start date
2016-08-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hand OA hand osteoarthritis

Interventions

The intervention is based on cognitive behavioral methods. It starts off with a face-to-face introduction consult. Subsequently, the tailored self-management intervention will be offered via an onli

Sponsors

Universiteit Leiden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosed with hand OA, following American College of Rheumatology (ARC) criteria - Referred to the hand OA care path - Complaints from hand OA including pain, with a minimal duration of 3 months - Minimum age of 18 years - Fluent in Dutch language - Able to give informed consent - Own a computer with internet access

Exclusion criteria

Exclusion criteria: - Difficulties in (written) communication (e.g. due to analfabetism) - Severe psychiatric comorbidities that interfere with the study protocol. - On-going psychological treatment elsewhere - Secondary OA due to diseases such as 1) inflammatory rheumatic diseases, as rheumatoid arthritis, psoriatic arthritis, etc, 2) bone diseases, as M. Paget, osteochondritis, 3) metabolic diseases associated with joint disease, as hemochromatosis, acromegaly, 4) severe crystal arthropathies, as topheus polyarticular gout.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be pain coping, measured with a VAS score.

Secondary

MeasureTime frame
As secondary outcomes, a number of other psychological and physical outcome measures will be assessed (e.g., HR-Qol, well-being, pain impact on daily life, pain cognitions). Additionally, the cost-effectiveness will be assessed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)